SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia

Abstract

Objectives: To examine seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in industry workers population sample. Methods: From 23 to April 28, 2020, we conducted serological testing for antibodies (Immunoglobulin G (IgG) and Immunoglobulin M (IgM)) on 1494 factory employees living in the Split-Dalmatia and Šibenik-Knin County (Croatia). Results: We detected antibodies in 1.27% of participants (95% confidence interval [CI] 0.77–1.98%). In Split facility 13/1316 (0.99%, 95% CI 0.53–1.68%) of participants were tested positive, of which 13/1079 (1.20%, 95% CI 0.64–2.05%) of those living outside the facility and 0/237 (0%, 95% CI 0–1.26%) of those living inside the facility. In Knin facility, 6/178 (3.37%, 95% CI 1.25–7.19%) participants were tested positive for antibodies. Conclusions: The study showed relatively small SARS-CoV-2 antibody seroprevalence in the DIV Group population sample.

Segurança e educação durante a COVID-19: prevalência, fatores associados e planos de reabertura da Faculdade de Enfermagem

“…These findings are compatible with other international studies, whose seroprevalence of SARS-CoV-2 was between 1 and 10%. [18][19][20][21][22] However, the data from this study differs from other studies based on the Brazilian population.…”

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya

“…Elsewhere, however, seroprevalence among non-HCWs has been much lower. SARS-CoV-2 antibody seroprevalence was 1% in Croatia, just prior to easing of nationwide COVID-19 restrictions in late April 2020[19]; 9-11% in France following the initial pandemic wave[20]; 20% in Chicago, Illinois, US during the summer of 2020 following easing of COVID-19 restrictions[21]; and 19-22% in Iran following the initial pandemic wave[22].…”

SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia

“…Several seroprevalence studies were conducted after the first pandemic wave, in specific population groups showing low seropositivity (1.27–5.19%) [ 11 , 12 , 13 ]. The prevalence of neutralizing (NT) antibodies was even lower (<1%) [ 12 ].…”